PRY is a 100% local GP/radiology/pathology business.
SHL only generates 9% of revenue from GP, 10% from radiology, and 29% from pathology in Australia.
The other 52% of revenue comes from global pathology with currency tailwinds.
Slight but important differences I think.
Also a milder cold/flu season shouldn't affect the pathology and radiology business too much as GPs don't do blood tests or X-rays frequently for these as they are usually mild to moderate illnesses.
TP=$20-$21?, page-2
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SHL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$26.20 |
Change
0.310(1.20%) |
Mkt cap ! $12.91B | |||
| Open | High | Low | Value | Volume |
| $25.86 | $26.27 | $25.79 | $23.17M | 887.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3120 | $26.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $26.30 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| SHL (ASX) Chart |
